Quick Answer
Aprea Therapeutics, Inc. reported Total Assets of $15.93 million for fiscal year 2025.
Aprea Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $15.93M | -33.6% |
| 2024 | $23.98M | +5.9% |
| 2023 | $22.65M | -24.9% |
| 2022 | $30.16M | -46.9% |
| 2021 | $56.82M | -38.8% |
| 2020 | $92.81M | -30.5% |
| 2019 | $133.61M | +102.4% |
| 2018 | $66.02M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.32M | -46.7% | -17.3% |
| June 30, 2025 | $17.31M | -42.2% | -14.4% |
| March 31, 2025 | $20.22M | -39.1% | -15.7% |
| December 31, 2024 | $23.98M | +5.9% | -10.8% |
| September 30, 2024 | $26.89M | +4.4% | -10.2% |
| June 30, 2024 | $29.96M | +4.5% | -9.7% |
| March 31, 2024 | $33.20M | +3.7% | +46.6% |
| December 31, 2023 | $22.65M | -24.9% | -12.1% |
- Aprea Therapeutics, Inc. showed a decrease of -33.6% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Aprea Therapeutics, Inc.’s total assets has declined by 75.9% (from $66.02 million to $15.93 million).
- The most recent figure is from Aprea Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: